Ross Bentley

1.7k total citations
33 papers, 951 citations indexed

About

Ross Bentley is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Ross Bentley has authored 33 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 11 papers in Hematology. Recurrent topics in Ross Bentley's work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Phosphodiesterase function and regulation (9 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Ross Bentley is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (10 papers), Phosphodiesterase function and regulation (9 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Ross Bentley collaborates with scholars based in United States, Switzerland and United Kingdom. Ross Bentley's co-authors include Paul J. Silver, L T Hamel, Mark H. Perrone, Alex L. Harris, Dale B. Evans, Robert J. Leadley, Charles Kasiewski, Valeria Chu, Paul C. Canniff and Christopher T. Dunwiddie and has published in prestigious journals such as Journal of Medicinal Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ross Bentley

33 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ross Bentley United States	19	375	369	212	143	112	33	951
Sandra Austin United States	12	365 1.0×	431 1.2×	144 0.7×	78 0.5×	123 1.1×	15	1.4k
Edward M. Driscoll United States	19	201 0.5×	512 1.4×	118 0.6×	61 0.4×	117 1.0×	41	1.1k
Marie A. Holahan United States	22	278 0.7×	206 0.6×	121 0.6×	173 1.2×	290 2.6×	50	1.1k
Yuzo Matsumoto Japan	23	256 0.7×	209 0.6×	88 0.4×	235 1.6×	273 2.4×	73	1.3k
J. Eileen Bird United States	21	305 0.8×	229 0.6×	164 0.8×	201 1.4×	114 1.0×	38	1.0k
Wolfram Steinke Germany	15	591 1.6×	487 1.3×	582 2.7×	134 0.9×	45 0.4×	31	1.7k
Anthony H. Ingall United Kingdom	12	240 0.6×	173 0.5×	85 0.4×	170 1.2×	89 0.8×	14	789
Wendy Tomlinson United Kingdom	11	210 0.6×	377 1.0×	66 0.3×	92 0.6×	131 1.2×	14	757
Larry R. Bush United States	22	329 0.9×	831 2.3×	148 0.7×	42 0.3×	224 2.0×	47	1.6k
Mark Rosolowsky United States	12	161 0.4×	320 0.9×	354 1.7×	47 0.3×	68 0.6×	22	960

Countries citing papers authored by Ross Bentley

Since Specialization

Citations

This map shows the geographic impact of Ross Bentley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Bentley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Bentley more than expected).

Fields of papers citing papers by Ross Bentley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Bentley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Bentley. The network helps show where Ross Bentley may publish in the future.

Co-authorship network of co-authors of Ross Bentley

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Bentley. A scholar is included among the top collaborators of Ross Bentley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Bentley. Ross Bentley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Tian‐Quan, Weizhen Wu, Myung K. Shin, et al.. (2015). Factor XII full and partial null in rat confers robust antithrombotic efficacy with no bleeding. Blood Coagulation & Fibrinolysis. 26(8). 893–902. 20 indexed citations

Willette, Robert N., Marianne Eybye, Alan R. Olzinski, et al.. (2009). Differential Effects of p38 Mitogen-Activated Protein Kinase and Cyclooxygenase 2 Inhibitors in a Model of Cardiovascular Disease. Journal of Pharmacology and Experimental Therapeutics. 330(3). 964–970. 37 indexed citations

Legos, Jeffrey J., Stephen C. Lenhard, Thomas Schaeffer, et al.. (2008). SB 234551 selective ETA receptor antagonism: Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Experimental Neurology. 212(1). 53–62. 35 indexed citations

Bao, Weike, David J. Behm, Sandhya S. Nerurkar, et al.. (2007). Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production. Journal of Cardiovascular Pharmacology. 49(6). 362–368. 89 indexed citations

Guertin, Kevin R., Scott I. Klein, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity. Bioorganic & Medicinal Chemistry Letters. 12(12). 1671–1674. 45 indexed citations

Rebello, Sam, Charles Kasiewski, Ross Bentley, et al.. (2001). Superiority of Enoxaparin Over Heparin in Combination With a GPIIb/IIIa Receptor Antagonist During Coronary Thrombolysis in Dogs. Thrombosis Research. 102(3). 261–271. 13 indexed citations

Rebello, Sam, Charles Kasiewski, Wei Wang, et al.. (2001). Role of Short-Term Inhibition of Factor Xa by FXV673 in Arterial Passivation: A Study in a Chronic Model of Thrombosis in Conscious Dogs. Journal of Cardiovascular Pharmacology. 38(2). 288–297. 9 indexed citations

Heran, Christopher L., Charles Kasiewski, Jeffrey S. Bostwick, et al.. (2000). Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis. European Journal of Pharmacology. 389(2-3). 201–207. 23 indexed citations

Becker, Michael R., William R. Ewing, Henry W. Pauls, et al.. (1999). Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(18). 2753–2758. 19 indexed citations

10.

Leadley, Robert J., Ross Bentley, Jeffrey S. Bostwick, et al.. (1999). Pharmacodynamic Activity and Antithrombotic Efficacy of RPR120844, a Novel Inhibitor of Coagulation Factor Xa. Journal of Cardiovascular Pharmacology. 34(6). 791–799. 15 indexed citations

11.

Choi-Sledeski, Yong Mi, Michael R. Becker, William R. Ewing, et al.. (1999). Aminoisoquinolines: Design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA. Bioorganic & Medicinal Chemistry Letters. 9(17). 2539–2544. 20 indexed citations

12.

Klein, Scott I., Bruce F. Molino, Valeria Chu, et al.. (1998). Design of a New Class of Orally Active Fibrinogen Receptor Antagonists. Journal of Medicinal Chemistry. 41(14). 2492–2502. 15 indexed citations

13.

Lord, Kenneth A., Xinmin Wang, R. Brückner, et al.. (1997). Variant cDNA Sequences of Human ATP:Citrate Lyase: Cloning, Expression, and Purification from Baculovirus-Infected Insect Cells. Protein Expression and Purification. 9(1). 133–141. 10 indexed citations

14.

Singh, Baldev, Edward R. Bacon, George Y. Lesher, et al.. (1995). Novel and Potent Adenosine 3',5'-Cyclic Phosphate Phosphodiesterase III Inhibitors: Thiazolo[4,5-b][1,6]naphthyridin-2-ones. Journal of Medicinal Chemistry. 38(14). 2546–2550. 24 indexed citations

15.

Silver, Paul J., et al.. (1991). Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.. Journal of Pharmacology and Experimental Therapeutics. 257(1). 382–391. 22 indexed citations

16.

Frangakis, Crist, et al.. (1989). The Role of Cyclic AMP and the Dihydropyridine-Sensitive Channels on the Mechanism of Action of Milrinone (Corotrope). Journal of Cardiovascular Pharmacology. 13(6). 915–924. 18 indexed citations

17.

Harris, Alex L., et al.. (1989). Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.. Journal of Pharmacology and Experimental Therapeutics. 249(2). 394–400. 48 indexed citations

18.

Farah, A., Paul C. Canniff, Ross Bentley, & Crist Frangakis. (1988). The Effect of Extracellular Ca2+ and Related Ions on the Cardiac Action of Milrinone. Journal of Cardiovascular Pharmacology. 11(5). 591–600. 13 indexed citations

19.

Silver, Paul J., et al.. (1988). Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.. Journal of Pharmacology and Experimental Therapeutics. 247(1). 34–42. 66 indexed citations

20.

Weston, Marla J., et al.. (1973). A Comparative Trial of Haloperidol and Thioridazine: Management of Chronic Schizophrenia. Australian & New Zealand Journal of Psychiatry. 7(1). 52–57. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact